Chengdu Zenitar Biomedical Technology Co., Ltd

This study tests a new drug called flonoltinib maleate in people with intermediate- or high-risk myelofibrosis, a rare bone marrow disorder. The main goal is to see if the drug can shrink the spleen by at least 35% and reduce symptoms like pain and fatigue. About 105 adults aged …

This study tests whether ZL-82 tablets can safely reduce eczema symptoms in adults with moderate to severe atopic dermatitis. About 111 participants will take either ZL-82 or a placebo daily for 16 weeks, with regular checkups to track skin improvement and side effects. The goal …

This study compares two drugs for people with diffuse large B-cell lymphoma that has come back or not responded to at least two prior treatments. About 390 adults will receive either purinostat mesylate (given by IV) or selinexor (taken as a pill). The goal is to see which drug w…

This study tests a new pill, flonoltinib maleate, in 60 adults with polycythemia vera (a blood disorder causing too many red blood cells) who have not responded to or cannot tolerate standard therapies. The goal is to see if the drug safely controls red blood cell levels without …

This study tests a new drug called Flonoltinib maleate in about 64 people with intermediate- or high-risk myelofibrosis, a rare bone marrow cancer. Participants must have tried and failed or not tolerated standard JAK inhibitor treatments. The main goal is to see if the drug can …